Ultraschall der Halsschlagader

Neben Wandbeschaffenheit, Flussgeschwindigkeit und -richtung werden allfällige Engstellen oder Verschlüsse dokumentiert. Die Vertebralarterie wird im Zuge dieser Untersuchung immer auch mit beurteilt.

Read More

Ultraschall der Venen

Damit kann eine Thrombose festgestellt, hinsichtlich des Ausmaßes beurteilt oder ausgeschlossen werden. Auch können Krampfadern so identifiziert werden. Zugänglichkeit für Verödungen etc. kann so beurteilt werden

Read More

Herzultraschall

damit kann Herzgröße und -funktion sowie Beschaffenheit der Herzklappen festgestellt werden. Bestimmung der Pumpleistung und Entspannung kann prognostisch wertvoll sein. Bei erhöhten Blutdruck eine wertvolle Untersuchung  

Read More

Ultraschall der Bauchaorta

Erweiterungen der Hauptschlagader, sogenannte Aneurysmen können mit Ultraschall sehr einfach festgestellt werden. Raucher sind häufiger davon betroffen und zeigen öfter zunehmendes Wachstum

Read More
  1. Renal Function and Long-term Mortality in Patients with asymptomatic Carotis Atherosclerosis (Thromb Haemost 2012;107:150-157)
  2. Incidence of Thrombotic and Bleeding Complications during Cardia Catheterization in Children: Comparison of High-dose versus Low-dose Heparin Protocols (J Thromb Haemost 2011;9:2353-2560)
  3. The prognostic impact of soluble apoptosis-stimulating fragment on mortality in patients with carotid atherosclerosis. (Stroke 2011;42:2465-70)
  4. The impact of dental disease on mortality in patients with asymptomatic carotid atherosclerosis. (Swiss Med Wkly 2011;141)
  5. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. (Stroke 2011;42:1826-33)
  6. Evidence of carotid atherosclerosis in orthopantomograms and the risk for future cardiovascular events. (Vasa 2010;39:298-304)
  7. Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis. (Stroke 2010;41:674-679)
  8. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. (Catheter Cardiovasc Interv 2009;74:1090-5)
  9. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. (Eur J Clin Invest 2009;39:784-792)
  10. Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease. (Atherosclerosis 2009;205:314-318)
  11. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. (Radiology 2008;248:1050-1055)
  12. Complications After Peripheral Vascular Interventions in Octogenarians (JEVT 2008;15:383-389)
  13. Decreasing Incidence of Critical Limb Ischemia After Intra-aortic Balloon Pump Counterpulsation. (Angiology 2009;60:235-41)
  14. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. (Radiology 2008;248:297-302)
  15. De Novo Superficial Femoropopliteal Artery Lesions: Peripheral Cutting Balloon Angioplasty and Restenosis Rates--Randomized Controlled Trial (Radiology 2008;247:267-272)
  16. Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk Patients. (Stroke 2007;38:2887-2894)
  17. Duplex Sonography Versus Angiography for Assessment of Femoropopliteal Arterial Disease in A "real-world" Setting. (JEVT 2007;14:452-9)
  18. Quality of Life After Balloon Angioplasty Versus Stent Implantation in the Superficial Femoral Artery: Findings from a Randomized Controlled Trial. (JEVT 2007;14:431-437)
  19. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. (Circulation 2007;115:2745-2749)
  20. C-Reactive Protein Predicts Future Cardiovascular Events in Patients With Carotid Stenosis (Stroke 2007;38:1263-1268)
  21. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease (EJCI 2007;37:180-186)
  22. Complement Component C5a Predicts Restenosis After Superficial Femoral Artery Balloon Angioplasty (JEVT 2007;14:62-69)
  23. Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease. (ATVB 2006;26:2536-2540)
  24. Dental and Periodontal Status and Risk for Progression of Carotid Atherosclerosis. The Inflammation and Carotid Artery Risk for Atherosclerosis Study Dental Substudy. (Stroke 2006;37:2271-2276)
  25. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. (JACC 2006;47:2212-2218)
  26. Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery (New Engl J Med 2006;354:1879-1888)
  27. Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature. (J Endovasc Ther 2006;13:221-8)
  28. Long-Segment SFA Stenting-The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent Fractures. (J Endovasc Ther 2005;12:676-684)
  29. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. (Eur J Clin Invest 2005;35 :731-737)
  30. Procedure-related complications and early neurological adverse events of unprotected and protected carotid stenting: temporal trends in a consecutive patient series. (J Endovasc Ther 2005;12:538-547)
  31. Association of a Functional Polymorphism in the Clopidogrel Target Receptor Gene, P2Y12, and the Risk for Ischemic Cerebrovascular Events in Patients With Peripheral Artery Disease. (Stroke 2005;36:1394-1399)
  32. Prognostic Impact of Fibrinogen in Carotid Atherosclerosis. Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression? (Stroke 2005;36:1400-1404)
  33. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. (J Vasc Surg 2005;41 :610-617)
  34. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). (Circulation 2005;111:2203-2209)
  35. Neurological outcome of conservative versus endovascular treatment of patients with asymptomatic high-grade carotid artery stenosis: a propensity score-adjusted analysis. (J Endovasc Ther 2005;12:145-155)
  36. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries (J Endovasc Ther 2005;12:6-12)
  37. Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients (J Vasc Interv Radiol 2005;16:31-5)
  38. High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting (Thromb Haemost 2004;92:1108-13)
  39. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis (Radiology 2004;232:516-21)
  40. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria (Radiology 2004;232:431-9)
  41. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions (Radiology 2004;231:831-8)
  42. Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations (Radiology 2004;231:839-44)
  43. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease (Eur Heart J 2004;25:742-8.)
  44. Long-term follow-up after percutaneous transluminal angioplasty of the distal abdominal aorta (Vasa 2004;33:49-51)
  45. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor (J Am Coll Cardiol 2004;43:950-7)
  46. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors (Thromb Haemost 2004;91:610-8)
  47. Contralateral High-Grade Carotid Artery Stenosis or Occlusion Is Not Associated with Increased Risk for Poor Neurologic Outcome after Elective Carotid Stent Placement (Radiology 2004;230:70-76)
  48. Endovascular Brachytherapy: Effect on Avute Inflammatory Response after percutaneous femoropopliteal arterial interventions (Radiology 2004;230:556-560)
  49. Low Serum Magnesiun predicts neurological events in patients with advanced atherosclerosis (Stroke 2004;35:22-27)
  50. Joint effects of C-reactive protein and glycated hemoglobin in predicting future events of patients with advanced atherosclerosis (Circulation 2003;108:2323-2328)
  51. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty (Thromb Haemost 2003;90:491-500)
  52. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up (J Endovasc Ther 2003;10:288-294)
  53. Restenosis after femoropopliteal PTA and elektive stent implantation: predictive value of monocyte counts (J Endovasc Ther 2003;10:557-565)
  54. Endovascular revascularization below the knee: 6 months results and predictive value of C-reactive protein level (Radiology 2003;227;419-425)
  55. Acute-phase response after stent implantation in the carotid artery: association with 6 month in-stent restenosis (Radiology 2003;227:516-521)
  56. Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis (Thromb Res 2002;108:279-285)
  57. Vascular Inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis (Radiology 2002;225:21-26)
  58. Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty (J Endovasc Ther 2002;9:385-94)
  59. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm (Thromb Res 2002;106:131-136)
  60. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries (Radiology 2002;224:529-35)
  61. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries (Thromb Haemost 2002;87:959-65)
  62. Outcome of conservative versus interventional treatment of subclavian artery stenosis (J Endovasc Ther 2002;9:139-46)
  63. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction (J Endovasc Ther 2002;9:59-66)
  64. Reduction in renal function after renal arteriography and after renal artery angioplasty (Eur J Vasc Endovasc 2002,24:156-160)
  65. Renal artery PTA and Stent implantation: Immediate and late clinical and morphological outcome (Wien Klin Wochenschr 2002;114:21-27)
  66. Carotid Artery Stenting in older patients: is age a risk factor for poor outcome? (J Endovasc Ther 2002;9:559-565)
  67. Relation of small artery compiance and Lipoprotein (a) in patients with atherosclerosis (Am J Hypertens 2002;15:980-985)
  68. Anti chlamydia antibodies in patients with thoracic and abdominal aortic aneurysms (Wien Klin Wochenschr 2002;23/24:972-977)
  69. Predicting renal failure after balloon angioplasty in high-risk patients (J Endovasc Ther 2001;8:609-14)
  70. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation (J Endovasc Ther 2001;8:477-83)
  71. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty (J Endovasc Ther 2001;8:433-40)

Kontaktieren Sie mich

Eine rasche Antwort ist Ihnen sicher

rufen Sie mich an
schreiben Sie mir

Interesse an einem Newsletter

melden Sie sich hier an